Hostname: page-component-54dcc4c588-5q6g5 Total loading time: 0 Render date: 2025-10-01T13:32:26.771Z Has data issue: false hasContentIssue false
  • English
  • Français

Premenstrual exacerbation of psychiatric symptoms: from misdiagnosis to management: commentary, Hudaib

Published online by Cambridge University Press:  11 August 2025

Abdul-Rahman Hudaib Open the ORCID record for Abdul-Rahman Hudaib [Opens in a new window]
Abdul-Rahman Hudaib*
Affiliation:
AIZH Statistics, Melbourne, Australia
*
Correspondence: Abdul-Rahman Hudaib. Email: Ahudaib@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Premenstrualexacerbationmanagementdepression

Information

Type
Commentary
Information
The British Journal of Psychiatry , First View , pp. 1 - 2
Check for updates
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Kulkarni, J, Mu, E. Premenstrual exacerbation of psychiatric symptoms: from misdiagnosis to management. Br J Psychiatry 2025; 226: 346–8.10.1192/bjp.2024.295CrossRefGoogle ScholarPubMed
Robertson, E, Thew, C, Thomas, N, Karimi, L, Kulkarni, J. Pilot data on the feasibility and clinical outcomes of a nomegestrol acetate oral contraceptive pill in women with premenstrual dysphoric disorder. Front Endocrinol 2021; 12: 704488.10.3389/fendo.2021.704488CrossRefGoogle ScholarPubMed
de Wit, AE, de Vries, YA, de Boer, MK, Scheper, C, Fokkema, A, Janssen, CAH, et al. Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials. Am J Obstet Gynecol 2021; 225: 624.10.1016/j.ajog.2021.06.090CrossRefGoogle ScholarPubMed
Ma, S, Song, SJ. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database of Systematic Reviews 2023; 6: CD006586.Google ScholarPubMed
Management of premenstrual disorders: ACOG clinical practice guideline No. 7. Obstet Gynecol 2023; 142: 1516.10.1097/AOG.0000000000005426CrossRefGoogle Scholar
Reilly, TJ, Wallman, P, Clark, I, Knox, C-L, Craig, MC, Taylor, D. Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: a systematic review and meta-analysis of randomised trials. J Psychopharmacol 2023; 37: 261–7.10.1177/02698811221099645CrossRefGoogle ScholarPubMed
Shechter, A, Lespérance, P, Ng Ying Kin, NMK, Boivin, DB. Pilot investigation of the circadian plasma melatonin rhythm across the menstrual cycle in a small group of women with premenstrual dysphoric disorder. PLoS One 2012; 7: e51929.10.1371/journal.pone.0051929CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.